LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 42.81 | 27.76 | 2261 | 3596 | 0.6287 | 0.8720 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 42.81 | 27.76 | 3199 | 3596 | 0.8895 | 0.9669 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 42.81 | 27.76 | 3232 | 3596 | 0.8987 | 0.9698 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 44.52 | 27.76 | 2400 | 3884 | 0.6179 | 0.8694 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 44.52 | 27.76 | 2419 | 3884 | 0.6228 | 0.8715 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 44.52 | 27.76 | 3423 | 3884 | 0.8812 | 0.9648 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 44.52 | 27.76 | 3453 | 3884 | 0.8890 | 0.9673 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 46.22 | 27.76 | 2548 | 4125 | 0.6177 | 0.8708 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 46.22 | 27.76 | 2568 | 4125 | 0.6226 | 0.8729 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 46.22 | 27.76 | 3612 | 4125 | 0.8756 | 0.9635 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 46.22 | 27.76 | 3644 | 4125 | 0.8834 | 0.9659 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.93 | 27.76 | 2681 | 4421 | 0.6064 | 0.8678 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.93 | 27.76 | 2693 | 4421 | 0.6091 | 0.8689 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.93 | 27.76 | 3767 | 4421 | 0.8520 | 0.9567 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.93 | 27.76 | 3793 | 4421 | 0.8579 | 0.9585 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 49.63 | 27.76 | 2804 | 4818 | 0.5820 | 0.8596 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 49.63 | 27.76 | 2818 | 4818 | 0.5849 | 0.8609 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 49.63 | 27.76 | 4010 | 4818 | 0.8323 | 0.9513 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 49.63 | 27.76 | 4024 | 4818 | 0.8352 | 0.9522 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 51.33 | 27.76 | 2931 | 5117 | 0.5728 | 0.8573 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 51.33 | 27.76 | 2947 | 5117 | 0.5759 | 0.8586 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 51.33 | 27.76 | 4179 | 5117 | 0.8167 | 0.9469 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 51.33 | 27.76 | 4201 | 5117 | 0.8210 | 0.9483 | MN20160318_Q01 | N08 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.04 | 27.76 | 3023 | 5365 | 0.5634 | 0.8545 | MN20160318_Q01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.04 | 27.76 | 3041 | 5365 | 0.5668 | 0.8559 | MN20160318_Q01 | C03 |